| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| sar425899 | glucagon | NA | Clinical trial target | TTD , DGIDB | Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] |
1.33 | phase 1 | unknown |
| sar425899 | glucagon receptor | NA | Successful target | TTD , DGIDB | Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] |
3.54 | phase 1 | agonist |
| sar425899 | glucagon receptor | NA | Successful target | TTD , DGIDB | Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] |
3.54 | phase 1 | unknown |
| sar425899 | glucagon-like peptide 1 receptor | NA | Successful target | TTD , DGIDB | Diabetes Mellitus Non-Insulin-Dependent[MeSHID:D003924] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Complications of Diabetes Mellitus[MeSHID:D048909] |
0.14 | phase 1 | unknown |
| click here to return to the previous page | ||||||||